The current study is the first to our knowledge to demonstrate that postnatal loss of DEPDC5 and subsequent hyperactivation of mTORC1 signaling is sufficient to recapitulate the DEPDC5-related epilepsy phenotypes of FCD II pathology and seizures. The gene discussed is DEPDC5; the disease is epilepsy.